Navigation Links
SemBioSys provides update on shrimp feed additive, Immunosphere(TM)
Date:5/16/2008

- Canadian Biotechnology Company's partner Aqua Bounty to scale back

commitment to immunostimulatory feed additive program -

TSX symbol: SBS

CALGARY, May 16 /PRNewswire-FirstCall/ - SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a portfolio of therapeutic proteins for metabolic and cardiovascular diseases, today announced that its joint development partner on the ImmunoSphere(TM) shrimp feed additive program, Aqua Bounty Technologies Inc. (AIM: ABTX), has announced that it intends to scale back marketing and registration efforts on its first generation shrimp feed additive, IMS. SemBioSys is developing a second generation shrimp feed additive product in safflower, ImmunoSphere(TM), that has the potential to significantly reduce the manufacturing costs of the feed additive.

"With this recent decision from Aqua Bounty related to its first generation shrimp feed additive product, we intend to evaluate the impact it has for our second generation product, ImmunoSphere(TM)," said Andrew Baum, President and CEO of SemBioSys Genetics Inc. "Our safflower-derived ImmunoSphere(TM) product offers a significant reduction to the cost of production of immunostimulatory feed additives. We intend to evaluate all of the available options prior to committing to next steps with this product which targets a large potential market that has a significant unmet need."

The global shrimp industry represents an US$18 billion market. One of the major challenges faced by commercial shrimp production is disease outbreak which cost the shrimp aquaculture industry more than US$3 billion per year. Immunostimulatory feed additives, like ImmunoSphere(TM), are designed to provide prophylactic protection to shrimp production.

About SemBioSys Genetics Inc. (http://www.sembiosys.com)

Calgary, Alberta-based SemBioSys Genetics Inc. is a biotechnol
'/>"/>

SOURCE SemBioSys Genetics Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. SemBioSys updates Apo AI development program
2. SemBioSys to present insulin data at the Seventh Annual Diabetes Technology Meeting
3. SemBioSys announces 2007 third quarter results
4. SemBioSys signs option agreement for safflower-produced food ingredient
5. SemBioSys to present at the 10th Annual BIO CEO & Investor Conference
6. SemBioSys awarded key patent for the production of oleosome emulsions by the European Patent Office
7. SemBioSys GLA Partner Enters Strategic Alliance for the Sales and Marketing of GLA-Rich Safflower Oil
8. SemBioSys announces 2007 financial and operational results
9. SemBioSys initiates toxicology study for safflower-produced insulin
10. SemBioSys receives milestone payments from AVAC Ltd.
11. SemBioSys announces first quarter 2008 financial and operational results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (T...") today announced updated results from a Phase II... sarcomas metastatic to the lung in a poster prese...ogy Society Meeting held in Miami Beach, Florida, ... entitled "A Phase II Study of Intravenous REOLYSI...
(Date:11/5/2009)..., Nov. 5 The endangered black-foot...n U.S. This rare carnivore feeds on prairie dogs.... and often entire population die-offs in towns occ...s implemented a ferret breeding program and has be...ormerly native habitat. Unfortunately, plague can...
(Date:11/5/2009)... 5 Transgenomic, Inc. (O... results for the quarter ended September 30, 2009....the tables that follow. ,, Third Quarter 2009 ... or $0.01 per share for the third quarter of 2009 ... share for the third quarter of 2008. ,, Net s...
(Date:11/5/2009)...Nov. 5 WaferGen Biosyste...eloper of state-of-the-art genetic analysis system...as joined the company,s Scientific Advisory Board....mercializing novel molecular diagnostics for cance...elopment of computational biology systems for seve...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2Transgenomic, Inc. Reports Third Quarter 2009 Results 2Transgenomic, Inc. Reports Third Quarter 2009 Results 3Transgenomic, Inc. Reports Third Quarter 2009 Results 4Transgenomic, Inc. Reports Third Quarter 2009 Results 5Transgenomic, Inc. Reports Third Quarter 2009 Results 6Transgenomic, Inc. Reports Third Quarter 2009 Results 7WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4
... Borer Technology Offers Greater Control of Common...or Southern U.S. Growers, ST. LOUIS, July 24 The...s deregulated MON 89034, a new insect,protection t...mercially, this,new above ground insect control te...ound and Roundup Ready technologies to be sold as ...
...ly 24 United,Therapeutics Corporation (Nasdaq: U...8 second quarter financial results before the open...erapeutics will host a half-hour teleconference on.... The teleconference is accessible,by dialing 1-80...06-679-8129. A rebroadcast of the teleconference w...
...4 Human Genome,Sciences, Inc. (Nasdaq: HGSI ) to...ointed to the HGS Board of Directors. He will also...e. Until recently, Mr. Southwell was,at Sepracor, ...re he served,as Executive Vice President and Chief...r Corporate Planning, Development and Licensing., ...
Other Biology Technology:New Insect Protection Technology From Monsanto Company Deregulated by USDA 2New Insect Protection Technology From Monsanto Company Deregulated by USDA 3Human Genome Sciences Appoints David P. Southwell to its Board of Directors 2Human Genome Sciences Appoints David P. Southwell to its Board of Directors 3Human Genome Sciences Appoints David P. Southwell to its Board of Directors 4
(Date:11/4/2009)...19 Spectros, developer and manufac...vices which shed light on life-threatening disease...stribution deals for both its T-Stat® VLS Tis...lude Australia, New Zealand, The Netherlands, Bel...e, Spain, Portugal, Poland, Greece, Turkey, and Ru...
(Date:11/4/2009)...ire/ -- What,s the cost of saving a teenage life? ...ting from prescription medication abuse, there,s n..., may be unaware that the lock-boxes they,ve insta...ng timebomb of prescription drugs. That,s why MEDN...al supplies, has formed an exclusive partnership w...
(Date:11/4/2009)... the University of North Carolina at Chapel Hill S..., San Francisco have developed and experimentally ...for existing drugs. , The researchers developed ...he structures of all known drugs are to the natura... -- of disease targets within the cell. In a study...
Breaking Biology News(10 mins):Spectros Signs New International Distribution Deals 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3Study points to new uses, unexpected side effects of already existing drugs 2Older patients with dementia at increased risk for flu mortality 60148 1Older patients with dementia at increased risk for flu mortality 60148 2The skeleton 3A Size matters 10538 1The skeleton 3A Size matters 10538 2Global Rainmakers Brings Cutting Edge Biometric Security Products to Reality 10534 1Global Rainmakers Brings Cutting Edge Biometric Security Products to Reality 10534 2Global Rainmakers Brings Cutting Edge Biometric Security Products to Reality 10534 3
..., Pittsburgh, PennsylvaniaResearchers from the Uni... of a newly discovered carnivorous animal, Puiji... a "missing link" in the evolution of the group th.... The analysis of the skeleton and support for the...the Arctic will be described in the April 23 issue...
..., The Rockefeller University and the Institute fo...hed a joint initiative in biology supported by a $... announced today. The initiative, which builds on ...he University, will involve biologists, mathematic... quantitative and theoretical approaches to biolog...
..., , PASADENA, Calif.--Some 25 years after the AIDS...ive vaccine against the human immunodeficiency vir...ctively become stalled. The reason? According to n...lifornia Institute of Technology (Caltech), it,s a...ural HIV antibodies simply don,t have a long enoug...
Other Biology News:Fossil evidence of missing link in the origin of seals, sea lions, walruses found in Canadian Arctic 2$10 million Simons Foundation gift supports new initiative with Institute for Advanced Study 2Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection 2Caltech scientists show why anti-HIV antibodies are ineffective at blocking infection 3
...K (c-Jun NH2-terminal kinase) signal transduction ...ways in mammals. JNK pathway activation occurs in ...th the nuclear accumulation of JNK itself, and is ...eration, oncogenic transformation, morphogenesis, ...
...oteomeLab PF 2D is an automated, two-dimensional f...f complex protein mixtures. Part of Beckman Coult...uces results in just hours. The system effectivel...ll lysates, addressing a key challenge in todays p...
...oteomeLab PA 800 is an automated, high-resolution ... ProteomeLab family of products, the PA 800 offers...terization solutions including molecular weight de..., carbohydrate profiling and mechanisms to study p...
...pid-Screen cDNA Library Panels were designed for f...s of PCRs to identify the desired cDNA clone. The ...er Plate," where each well contains plasmid DNA fr...ll(s) by gel electrophoresis of the reaction produ...
Biology Products: